Institutional Ownership
Io Biotech Inc
CUSIP 449778109COMIOBTQQ1 2026
13D / 13G Filings
35
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
29.6%
Max % of class reported
Institutional Holders
12
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
35 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | Chernett Jorey | 13G/A | 6.3% | 4.54M | SEC |
| 2 | Feb 6, 2026 | Point72 Asset Management, L.P. | 13G | 5.6% | 4.03M | SEC |
| 3 | Jan 23, 2026 | Novo Holdings A/S | 13D/A | 3.3% | — | SEC |
| 4 | Nov 14, 2025 | Vivo Capital Ix, LLC | 13G/A | 4.6% | 3.16M | SEC |
| 5 | Nov 5, 2025 | Chernett Jorey | 13G | 5.3% | 3.48M | SEC |
| 6 | Aug 19, 2025 | Novo Holdings A/S | 13D/A | 7.3% | — | SEC |
| 7 | Feb 14, 2025 | Samsara Biocapital, L.P. | 13G/A | 3.8% | 2.63M | SEC |
| 8 | Feb 13, 2025 | Hbm Healthcare Investments (Cayman) Ltd. | 13G/A | 8.2% | 5.52M | SEC |
| 9 | Nov 13, 2024 | Stonepine Capital Management, LLC | 13G/A | — | — | SEC |
| 10 | Sep 17, 2024 | Novo Holdings A/S | 13D/A | 8.5% | 5.82M | SEC |
25 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Io Biotech Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ikarian Capital, LLC | 1.39M | $81.4K |
| 2 | Boothbay Fund Management, LLC | 451.9K | $26.5K |
| 3 | Marshall Wace, LLP | 301.3K | $18.1K |
| 4 | Xtx Topco Ltd | 265.8K | $15.6K |
| 5 | Morgan Stanley | 206.2K | $12.1K |
| 6 | Millennium Management LLC | 194.2K | $11.4K |
| 7 | Citigroup Inc | 72.5K | $4.3K |
| 8 | Jane Street Group, LLC | 58.0K | $3.4K |
| 9 | Beacon Pointe Advisors, LLC | 42.6K | $2.5K |
| 10 | Geode Capital Management, LLC | 33.3K | $2.0K |